Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial.
Wataya-Kaneda M, Nagai H, Ohno Y, Yokozeki H, Fujita Y, Niizeki H, Yoshida K, Ogai M, Yoshida Y, Asahina A, Fukai K, Tateishi C, Hamada I, Takahata T, Shimizu K, Shimasaki S, Murota H. Wataya-Kaneda M, et al. Among authors: yokozeki h. Dermatol Ther (Heidelb). 2020 Aug;10(4):635-650. doi: 10.1007/s13555-020-00387-7. Epub 2020 May 8. Dermatol Ther (Heidelb). 2020. PMID: 32385845 Free PMC article.
Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.
Wataya-Kaneda M, Ohno Y, Fujita Y, Yokozeki H, Niizeki H, Ogai M, Fukai K, Nagai H, Yoshida Y, Hamada I, Hio T, Shimizu K, Murota H. Wataya-Kaneda M, et al. Among authors: yokozeki h. JAMA Dermatol. 2018 Jul 1;154(7):781-788. doi: 10.1001/jamadermatol.2018.1408. JAMA Dermatol. 2018. PMID: 29800026 Free PMC article. Clinical Trial.
A phase III, 52-week, open-label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis.
Fujimoto T, Abe Y, Igarashi M, Ishikoh A, Omi T, Kanda H, Kitahara H, Kinoshita M, Nakasu I, Hattori N, Horiuchi Y, Maruyama R, Mizutani H, Murakami Y, Watanabe C, Kume A, Hanafusa T, Hamaguchi M, Yoshioka A, Egami Y, Matsuo K, Matsuda T, Akamatsu M, Yorozuya T, Takayama S, Yokozeki H. Fujimoto T, et al. Among authors: yokozeki h. J Dermatol. 2021 Aug;48(8):1149-1161. doi: 10.1111/1346-8138.15927. Epub 2021 May 26. J Dermatol. 2021. PMID: 34041788 Free PMC article. Clinical Trial.
Cost-of-illness study for axillary hyperhidrosis in Japan.
Murota H, Fujimoto T, Oshima Y, Tamada Y, Yanagishita T, Murayama N, Inoue S, Okatsu H, Miyama H, Yokozeki H. Murota H, et al. Among authors: yokozeki h. J Dermatol. 2021 Oct;48(10):1482-1490. doi: 10.1111/1346-8138.16050. Epub 2021 Jul 9. J Dermatol. 2021. PMID: 34245048 Free PMC article.
2020 guidelines for the diagnosis and treatment of cutaneous pruritus.
Satoh T, Yokozeki H, Murota H, Tokura Y, Kabashima K, Takamori K, Shiohara T, Morita E, Aiba S, Aoyama Y, Hashimoto T, Katayama I. Satoh T, et al. Among authors: yokozeki h. J Dermatol. 2021 Sep;48(9):e399-e413. doi: 10.1111/1346-8138.16066. Epub 2021 Jul 20. J Dermatol. 2021. PMID: 34288036
2020 guidelines for the diagnosis and treatment of prurigo.
Satoh T, Yokozeki H, Murota H, Tokura Y, Kabashima K, Takamori K, Shiohara T, Morita E, Aiba S, Aoyama Y, Hashimoto T, Katayama I. Satoh T, et al. Among authors: yokozeki h. J Dermatol. 2021 Sep;48(9):e414-e431. doi: 10.1111/1346-8138.16067. Epub 2021 Jul 27. J Dermatol. 2021. PMID: 34314056
389 results